W. J. Guan, Z. Y. Ni, Y. Hu, W. H. Liang, C. Q. Ou et al., Clinical characteristics of coronavirus disease 2019 in China, The New England Journal of Medicine, 2020.

M. Z. Ratajczak, How to "Detronize" virus in crownquestions to current stem cell therapies, Stem Cell Reviews and Reports, 2020.

F. Zhou, T. Yu, R. Du, G. Fan, Y. Liu et al., Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study, Lancet, 2020.

F. D'amico, D. C. Baumgart, S. Danese, and L. Peyrin-biroulet, Diarrhea during COVID-19 infection: pathogenesis, epidemiology, prevention and management, Clinical Gastroenterology and Hepatology, 2020.

I. Hamming, W. Timens, M. L. Bulthuis, A. T. Lely, G. Navis et al., Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis, The Journal of Pathology, vol.203, issue.2, pp.631-637, 2004.

, Stem Cell Rev and Rep, vol.5

Y. P. Jarajapu, Targeting ACE2/Angiotensin-(1-7)/Mas receptor axis in the vascular progenitor cells for cardiovascular diseases, Molecular Pharmacology, 2020.

S. Joshi, S. Mahoney, J. Jahan, L. Pitts, K. J. Hackney et al., Blood Flow Restriction Exercise Stimulates Mobilization of Hematopoietic Stem/Progenitor Cells and Increases the Circulating ACE2 Levels in Healthy adults, Journal of Applied Physiology, 1985.

S. Heringer-walther, K. Eckert, S. M. Schumacher, L. Uharek, A. Wulf-goldenberg et al., Angiotensin-(1-7) stimulates hematopoietic progenitor cells in vitro and in vivo, Haematologica, vol.94, issue.6, pp.857-860, 2009.

H. Ulrich and M. M. Pillat, CD147 as a Target for COVID-19 Treatment: Suggested Effects of Azithromycin and Stem Cell Engagement, Stem Cell Reviews and Reports, 2020.

C. Crosnier, L. Y. Bustamante, S. J. Bartholdson, A. K. Bei, M. Theron et al., Basigin is a receptor essential for erythrocyte invasion by Plasmodium falciparum, Nature, vol.480, issue.7378, pp.534-541, 2011.

S. C. Bernard, N. Simpson, O. Join-lambert, C. Federici, M. P. Laran-chich et al., Pathogenic Neisseria meningitidis utilizes CD147 for vascular colonization, Nature Medicine, vol.20, issue.7, pp.725-731, 2014.

K. Higashi, M. Yagi, T. Arakawa, K. Asano, K. Kobayashi et al., A novel marker for undifferentiated human embryonic stem cells, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, vol.34, issue.1, pp.7-11, 2015.

E. Amati, O. Perbellini, G. Rotta, M. Bernardi, K. Chieregato et al., High-throughput immunophenotypic characterization of bone marrow-and cord blood-derived mesenchymal stromal cells reveals common and differentially expressed markers: identification of angiotensin-converting enzyme (CD143) as a marker differentially expressed between adult and perinatal tissue sources, Stem Cell Research & Therapy, vol.9, issue.1, p.10, 2018.

M. Hoffmann, H. Kleine-weber, S. Schroeder, N. Kruger, T. Herrler et al., SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor, Cell, 2020.

R. Lu, X. Zhao, J. Li, P. Niu, B. Yang et al., Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding, Lancet, vol.395, pp.565-574, 2020.

J. M. Michot, L. Albiges, N. Chaput, V. Saada, F. Pommeret et al., Tocilizumab, an anti-IL6 receptor antibody, to treat Covid-19-related respiratory failure: a case report, Annals of Oncology, 2020.

L. Tan, Q. Wang, D. Zhang, J. Ding, Q. Huang et al., Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study, Signal Transduction and Targeted Therapy, vol.5, p.33, 2020.

B. Xu, C. Y. Fan, A. L. Wang, Y. L. Zou, Y. H. Yu et al., Suppressed T cell-mediated immunity in patients with COVID-19: a clinical retrospective study in Wuhan, China. The Journal of Infection, 2020.

I. Quinti, V. Lougaris, C. Milito, F. Cinetto, A. Pecoraro et al., A possible role for B cells in COVID-19?: lesson from patients with Agammaglobulinemia, The Journal of Allergy and Clinical Immunology, 2020.

O. Grimsholm, E. Piano-mortari, A. N. Davydov, M. Shugay, A. S. Obraztsova et al., The interplay between CD27(dull) and CD27(bright) B cells ensures the flexibility, stability, and resilience of human B cell memory, Cell Reports, vol.30, issue.9, pp.2963-2977, 2020.

A. , E. Becker, C. Bergmeier, W. Bode, C. Bourne et al., Thrombo-Inflammation in Cardiovascular Disease: An Expert Consensus Document from the Third Maastricht Consensus Conference on Thrombosis. Thrombosis and Haemostasis, vol.120, pp.538-564, 2020.

N. Tang, D. Li, X. Wang, and Z. Sun, Abnormal Coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia, Journal of Thrombosis and Haemostasis, 2020.

H. Han, L. Yang, R. Liu, F. Liu, K. L. Wu et al., Prominent changes in blood coagulation of patients with SARS-CoV-2 infection, Clinical Chemistry and Laboratory Medicine, 2020.

Y. Zhang, M. Xiao, S. Zhang, P. Xia, W. Cao et al., Coagulopathy and antiphospholipid antibodies in patients with Covid-19, The New England Journal of Medicine, vol.382, issue.17, p.38, 2020.

I. Harzallah, A. Debliquis, and B. Drenou, Lupus anticoagulant is frequent in patients with Covid-19, Journal of Thrombosis and Haemostasis, 2020.

J. Thachil, N. Tang, S. Gando, A. Falanga, M. Cattaneo et al., ISTH interim guidance on recognition and management of coagulopathy in COVID-19, Journal of Thrombosis and Haemostasis, 2020.

N. Tang, H. Bai, X. Chen, J. Gong, D. Li et al., Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy, Journal of Thrombosis and Haemostasis, 2020.

J. Poissy, J. Goutay, M. Caplan, E. Parmentier, T. Duburcq et al., Pulmonary embolism in COVID-19 patients: awareness of an increased prevalence, 2020.

Z. Varga, A. J. Flammer, P. Steiger, M. Haberecker, R. Andermatt et al., Endothelial cell infection and endotheliitis in COVID-19, 2020.

V. Monteil, H. Kwon, P. Prado, A. Hagelkruys, R. A. Wimmer et al., Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2, Cell, 2020.

S. D. Qanadli, C. Beigelman-aubry, and D. C. Rotzinger, Vascular changes detected with thoracic CT in coronavirus disease (COVID-19) might be significant determinants for accurate diagnosis and optimal patient management, AJR. American Journal of Roentgenology. W1, 2020.

D. M. Smadja, C. Audigier, C. L. Guerin, L. Mauge, B. Dizier et al., Angiogenic potential of BM MSCs derived from patients with critical leg ischemia, Bone Marrow Transplantation, vol.47, issue.7, pp.997-1000, 2012.

J. M. Melero-martin, M. E. De-obaldia, S. Y. Kang, Z. A. Khan, L. Yuan et al., Engineering robust and functional vascular networks in vivo with human adult and cord bloodderived progenitor cells, Circulation Research, vol.103, issue.2, pp.194-202, 2008.

D. M. Smadja, M. Levy, L. Huang, E. Rossi, A. Blandinieres et al., Treprostinil indirectly regulates endothelial colony forming cell angiogenic properties by increasing VEGF-A produced by mesenchymal stem cells, Thrombosis and Haemostasis, vol.114, issue.4, 2015.

E. Rossi, C. Goyard, A. Cras, B. Dizier, N. Bacha et al., Co-injection of mesenchymal stem cells with endothelial progenitor cells accelerates muscle recovery in hind limb ischemia through an endoglin-dependent mechanism, Thrombosis and Haemostasis, vol.117, issue.10, pp.1908-1918, 2017.

J. M. Melero-martin, Z. A. Khan, A. Picard, X. Wu, S. Paruchuri et al., In vivo vasculogenic potential of human blood-derived endothelial progenitor cells, Blood, vol.109, issue.11, pp.4761-4768, 2007.

P. Au, J. Tam, D. Fukumura, and R. K. Jain, Bone marrowderived mesenchymal stem cells facilitate engineering of longlasting functional vasculature, Blood, vol.111, issue.9, pp.4551-4558, 2008.

E. Rossi, C. Bernabeu, and D. M. Smadja, Endoglin as an adhesion molecule in mature and progenitor endothelial cells: a function beyond TGF-beta, Frontiers in Medicine, vol.6, p.10, 2019.

R. Shammaa, A. E. El-kadiry, J. Abusarah, and M. Rafei, Mesenchymal Stem Cells Beyond Regenerative Medicine, Frontiers in Cell and Development Biology, vol.8, p.72, 2020.

A. Golchin, E. Seyedjafari, and A. Ardeshirylajimi, Mesenchymal stem cell therapy for COVID-19: present or future, Stem Cell Reviews and Reports, 2020.

Z. Leng, R. Zhu, W. Hou, Y. Feng, Y. Yang et al., Transplantation of ACE2(-) Mesenchymal Stem Cells Improves the Outcome of Patients with COVID-19 Pneumonia, Aging and Disease, vol.11, issue.2, pp.216-228, 2020.

E. Bari, I. Ferrarotti, L. Saracino, S. Perteghella, M. L. Torre et al., Mesenchymal stromal cell secretome for severe COVID-19 infections: premises for the therapeutic use, Cells, issue.4, p.9, 2020.

M. Z. Ratajczak, M. Kucia, T. Jadczyk, N. J. Greco, W. Wojakowski et al., Pivotal role of paracrine effects in stem cell therapies in regenerative medicine: can we translate stem cell-secreted paracrine factors and microvesicles into better therapeutic strategies?, Leukemia, vol.26, issue.6, pp.1166-1173, 2012.

C. L. Guerin, E. Rossi, B. Saubamea, A. Cras, V. Mignon et al., Human very small embryonic-like cells support vascular maturation and therapeutic revascularization induced by endothelial progenitor cells, Stem Cell Reviews, vol.13, issue.4, pp.552-560, 2017.

C. L. Guerin, X. Loyer, J. Vilar, A. Cras, T. Mirault et al., Bone-marrow-derived very small embryonic-like stem cells in patients with critical leg ischaemia: evidence of vasculogenic potential, Thrombosis and Haemostasis, vol.113, issue.5, pp.1084-1094, 2015.

D. M. Smadja, Bone marrow very small embryonic-like stem cells: new generation of autologous cell therapy soon ready for prime time?, Stem Cell Reviews, vol.13, issue.2, pp.198-201, 2017.
URL : https://hal.archives-ouvertes.fr/inserm-01446765

B. Dawn, S. Tiwari, M. J. Kucia, E. K. Zuba-surma, Y. Guo et al., Transplantation of bone marrowderived very small embryonic-like stem cells attenuates left ventricular dysfunction and remodeling after myocardial infarction, Stem Cells, vol.26, issue.6, pp.1646-1655, 2008.

W. Wojakowski, M. Tendera, M. Kucia, E. Zuba-surma, K. Milewski et al., Cardiomyocyte differentiation of bone marrow-derived Oct-4 + CXCR4 + SSEA-1 + very small embryonic-like stem cells, International Journal of Oncology, vol.37, issue.2, pp.237-247, 2010.

C. L. Guerin, A. Blandinieres, B. Planquette, J. S. Silvestre, D. Israel-biet et al., Very Small Embryoniclike Stem Cells Are Mobilized in Human Peripheral Blood during Hypoxemic COPD Exacerbations and Pulmonary Hypertension, Stem Cell Reviews, vol.13, issue.4, pp.561-566, 2017.

S. H. Kassmer, H. Jin, P. X. Zhang, E. M. Bruscia, K. Heydari et al., Very small embryonic-like stem cells from the murine bone marrow differentiate into epithelial cells of the lung, Stem Cells, issue.12, pp.2759-2766, 2013.

M. Z. Ratajczak, J. Ratajczak, M. Suszynska, D. M. Miller, M. Kucia et al., Novel view of the adult stem cell compartment from the perspective of a quiescent population of very small embryonic-like stem cells, Circulation Research, vol.120, issue.1, pp.166-178, 2017.

, Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations